![Immunology / Drugs / Targeted therapy / Ovarian cancer / Monoclonal antibodies / Bevacizumab / Breast cancer treatment / Medicine / Pharmacology / Immune system Immunology / Drugs / Targeted therapy / Ovarian cancer / Monoclonal antibodies / Bevacizumab / Breast cancer treatment / Medicine / Pharmacology / Immune system](https://www.pdfsearch.io/img/37bc582e2312c7ffa4178998879d8450.jpg) Date: 2015-03-26 10:59:50Immunology Drugs Targeted therapy Ovarian cancer Monoclonal antibodies Bevacizumab Breast cancer treatment Medicine Pharmacology Immune system | | GAMAMABS PHARMA One line pitch: Gamamabs develops innovative antibodies which activate effector cells in oncology. Gamamabs lead antibody is in pre-IMPD stage and targets AMHRII in ovarian cancer Market Analysis:Add to Reading ListSource URL: www.biovision.orgDownload Document from Source Website File Size: 799,08 KBShare Document on Facebook
|